ArticleFrontiers in oncology2022

The Efficacy and Safety of Sintilimab Combined With Nab-Paclitaxel as a Second-Line Treatment for Advanced or Metastatic Gastric Cancer and Gastroesophageal Junction Cancer.

Jianzheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.